GF

Pancreatic cancer: a silent killer striking more young people and rarely caught in time

VUB researchers and doctors call for greater focus on early detection and prevention during World Pancreatic Cancer Month

Researchers Develop Innovative Phage-Based Strategy Against Multidrug-Resistant Bacteria

Unique dataset sheds new light on long-term survival in invasive breast cancer

How do treatments and socio-economic conditions affect the long-term survival chances of women with breast cancer?

Three VUB researchers receive prestigious ERC Starting Grants

Thanks to ERC support, three VUB researchers are launching groundbreaking research into urban inequality, childhood diabetes, and male infertility.

VUB Professor Jan Steyaert receives ERC Proof of Concept Grant

Intensive Guidance of COPD Patients by Hospital Pharmacists Shows Clear Added Value

Closer follow-up leads to better use of inhalation medication

Nav1.9: The Hidden Switch in Pain and Itch

New research reveals how a channel protein could lead to better pain relief

Better Symptom Screening in Multiple Sclerosis Thanks to New App by VUB and UZ Brussel Researchers

"A Digital Alternative for Cognitive and Motor Function Monitoring"

VUB study reveals increased risk of frailty in older adults due to medication use

VUB Research Team Presents Innovative Local Treatment for Osteolytic Bone Disease in Multiple Myeloma

A team of researchers from the Translational Oncology Research Centre (TORC) of Vrije Universiteit Brussel (VUB), in collaboration with leading German universities, has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a promising approach to bone healing and tumor control.

Tailored Cancer Treatment: VUB Research Predicts Which Patients Benefit from Immunotherapy

A team of scientists led by researchers from the Vrije Universiteit Brussel (VUB) and the Flemish Institute for Biotechnology (VIB) has developed a new technology to precisely predict and monitor cancer patients' responses to immunotherapy.